ripekg:retraction-notice/50503Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicin |
http://purl.org/spar/cito/retracts |
ripekg:work/10.3389%2Ffonc.2020.588533 |
ripekg:retraction-notice/50503Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicin |
ripe:concerns |
ripekg:work/10.3389%2Ffonc.2020.588533 |
ripekg:work/10.3389%2Ffonc.2020.588533 |
prism:doi |
10.3389/fonc.2020.588533 |
ripekg:work/10.3389%2Ffonc.2020.588533 |
prism:publicationDate |
2021-02-09 |
ripekg:work/10.3389%2Ffonc.2020.588533 |
rdf:type |
node1 |
ripekg:work/10.3389%2Ffonc.2020.588533 |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.3389%2Ffonc.2020.588533 |
rdf:type |
rdfs:Resource |
ripekg:work/10.3389%2Ffonc.2020.588533 |
rdf:type |
owl:Thing |
ripekg:work/10.3389%2Ffonc.2020.588533 |
rdf:type |
prov:Entity |
ripekg:work/10.3389%2Ffonc.2020.588533 |
rdf:type |
ripe:WorkWork |
ripekg:work/10.3389%2Ffonc.2020.588533 |
owl:sameAs |
https://semopenalex.org/work/W4255753029 |